1. Home
  2. JYNT vs RCEL Comparison

JYNT vs RCEL Comparison

Compare JYNT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.94

Market Cap

118.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$5.04

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
RCEL
Founded
2010
N/A
Country
United States
United States
Employees
N/A
226
Industry
Multi-Sector Companies
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.2M
126.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
JYNT
RCEL
Price
$8.94
$5.04
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$17.00
$7.88
AVG Volume (30 Days)
177.6K
346.8K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
N/A
EPS
0.09
N/A
Revenue
$117,696,356.00
N/A
Revenue This Year
$12.23
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
$99.67
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$3.22
52 Week High
$12.27
$7.12

Technical Indicators

Market Signals
Indicator
JYNT
RCEL
Relative Strength Index (RSI) 51.54 71.78
Support Level $8.01 $5.03
Resistance Level $9.25 $5.13
Average True Range (ATR) 0.54 0.29
MACD -0.03 0.11
Stochastic Oscillator 47.59 97.08

Price Performance

Historical Comparison
JYNT
RCEL

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: